Adverse reactions to rifampicin in antituberculosis regimens.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000209:etiology; D000743:Anemia, Hemolytic / Q000139:chemically induced / Q000209:etiology; D004064:Digestive System / Q000503:physiopathology; D006801:Humans; D007251:Influenza, Human / Q000139:chemically induced / Q000209:etiology; D008099:Liver / Q000503:physiopathology; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000503:physiopathology; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced / Q000209:etiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology
D012293:Rifampin